BALANGODA PLANTATIONS PLC Financial Summary
BALA.N0000 · BALANGODA PLANTATIONS PLC · Food, Beverage & Tobacco · 2026-08-15
Balangoda Plantations PLC Financial Summary and Investment Analysis
Executive Overview
Balangoda Plantations PLC is a plantation company engaged principally in tea, rubber, forestry products and other crops, operating 21 estates across Balangoda, Badulla and Ratnapura. The Company manages approximately 3,931 hectares of tea and 1,858 hectares of rubber, with total tea, rubber, timber and other crop fields spanning about 9,076 hectares. Melstacorp PLC is the parent company.
Periods covered: Q3 2023 through Q2 2026, audited CY2025 Annual Report, historical annual information through CY2020, and market context through 2026-08-14.
The central financial trend is a sharp weakening of core plantation margins after the strong 2024 period. Audited CY2025 revenue declined 11.6% to Rs.4,279.555 million and gross profit fell 52.6% to Rs.411.506 million. H1 2026 deteriorated further, recording a gross loss of Rs.12.983 million, although biological-asset fair-value gains and other income preserved a Rs.130.122 million net profit.
The balance sheet is considerably stronger than several years ago: equity reached Rs.4,627.987 million by 2026-06-30, there were no term borrowings, and NAV rose to Rs.97.90/share. However, H1 2026 operating cash generation almost disappeared and overdraft usage increased.
Financial Performance
Revenue and Profitability Trends
*Rs.'000; quarterly numbers are those reported in each interim. Later audited annual totals supersede unaudited year-end totals.*
| Period | Revenue | Gross Profit | Net Profit/(Loss) | GP Margin | NP Margin |
|---|---|---|---|---|---|
| Q3 2023 | 1,017,306 | 131,080 | 42,081 | 12.9% | 4.1% |
| Q4 2023 | 835,510 | 27,847 | 15,477 | 3.3% | 1.9% |
| Q1 2024 | 1,116,660 | 166,557 | 167,733 | 14.9% | 15.0% |
| Q2 2024 | 1,343,982 | 360,347 | 289,108 | 26.8% | 21.5% |
| Q3 2024 | 1,237,654 | 288,365 | 265,172 | 23.3% | 21.4% |
| Q4 2024 | 1,175,524 | 30,303 | 50,785 | 2.6% | 4.3% |
| Q1 2025 | 997,385 | 82,215 | 132,248 | 8.2% | 13.3% |
| Q2 2025 | 1,221,326 | 152,952 | 240,477 | 12.5% | 19.7% |
| Q3 2025 | 1,157,941 | 142,617 | 123,784 | 12.3% | 10.7% |
| Q4 2025 | 902,903 | 47,174 | 124,097 | 5.2% | 13.7% |
| Q1 2026 | 843,154 | (117,724) | (41,165) | -14.0% | -4.9% |
| Q2 2026 | 1,089,427 | 104,742 | 171,288 | 9.6% | 15.7% |
Q2 2026 showed a meaningful sequential recovery from Q1: revenue increased 29.2%, gross profitability returned, and the Rs.41.165 million Q1 loss became a Rs.171.288 million profit. Nevertheless, Q2 revenue remained 10.8% below Q2 2025 and net profit was down 28.8% YoY.
For H1 2026, revenue fell 12.9% YoY to Rs.1,932.581 million and PAT declined 65.1% to Rs.130.122 million. More significantly, H1 gross profit moved from Rs.235.167 million in 2025 to a Rs.12.983 million gross loss.
Audited CY2025 results were:
- Revenue: Rs.4,279.555 million, -11.6%.
- Gross profit: Rs.411.506 million, -52.6%.
- Operating profit: Rs.944.947 million, -15.1%.
- PBT: Rs.858.495 million, -10.3%.
- PAT: Rs.596.685 million, -19.5%.
- EPS: Rs.12.62, versus Rs.15.68.
- Net margin: 13.9%, versus approximately 15.3%.
The 35% plantation wage increase added approximately Rs.266 million of annual labour cost.
Profit Quality and Segments
Profit increasingly depends on non-core/non-cash valuation income. CY2025 biological-asset fair-value gains were Rs.518.890 million, exceeding reported gross profit. Excluding this gain, PBT would have been approximately Rs.339.605 million before other adjustments.
This became more pronounced in H1 2026: PBT was Rs.201.018 million while biological-asset fair-value gains were Rs.200.195 million. Core plantation operations therefore generated very little pre-tax profitability independently of valuation gains and other income.
| Segment | CY2025 Revenue | Gross Profit/(Loss) | Gross Margin | H1 2026 Gross Margin |
|---|---|---|---|---|
| Tea | 3,834,986 | 482,007 | 12.6% | 2.8% |
| Rubber | 444,569 | (70,501) | -15.9% | -27.2% |
Tea remains the earnings engine, but its margin has compressed sharply. Rubber remains structurally loss-making at gross-profit level despite stronger selling prices.
Balance Sheet Analysis
| Rs.'000 | 2024-12-31 | 2025-12-31 | 2026-06-30 |
|---|---|---|---|
| Total assets | 8,059,127 | 8,954,100 | 9,166,221 |
| Current assets | 764,572 | 777,801 | 827,609 |
| Current liabilities | 914,686 | 744,084 | 728,779 |
| Total equity | 3,717,021 | 4,498,048 | 4,627,987 |
| Cash | 43,273 | 17,139 | 3,269 |
| Bank overdraft | 302,058 | 103,930 | 174,289 |
| NAV/share | 78.63 | 95.15 | 97.90 |
| Current ratio | 0.84x | 1.05x | ~1.14x |
Equity strengthened 21% during CY2025, supported by profitability and revaluations. CY2025 included a Rs.386.678 million building revaluation surplus before related deferred tax.
Term borrowings were fully repaid, materially reducing financial leverage. However, H1 2026 liquidity quality weakened: cash fell to only Rs.3.269 million while the overdraft increased 67.7% from year-end to Rs.174.289 million.
Biological assets remain exceptionally material: bearer and consumable biological assets totaled about Rs.5.582 billion, approximately 61% of assets at 2026-06-30.
Cash Flow Analysis
CY2025 operating cash flow declined from Rs.1,110.382 million to Rs.481.752 million. Capital investment was approximately Rs.154 million, implying free cash generation of roughly Rs.327 million.
H1 2026 deteriorated sharply:
| Rs.'000 | H1 2025 | H1 2026 |
|---|---|---|
| Operating cash flow | 226,467 | 4,434 |
| Investing cash flow | (7,231) | (50,651) |
| Financing cash flow | (169,247) | (38,012) |
| Period-end net cash/(overdraft) | (208,795) | (171,020) |
Approximate H1 2026 free cash flow after Rs.71.739 million capital expenditure was negative Rs.67 million. Receivables, inventories and lower payables absorbed cash.
Key Financial Ratios and Growth Indicators
| Indicator | CY2025 |
|---|---|
| Gross margin | 9.6% |
| Operating margin | 22.1% |
| Net margin | 13.9% |
| Approx. ROE | 14.5% |
| Reported return on assets | 11% |
| Current ratio | 1.05x |
| Quick ratio | 0.39x |
| Interest cover | 10.69x |
| Debt/total assets | 0.02x |
| Asset turnover | 0.5x |
| EPS | Rs.12.62 |
| NAV/share | Rs.95.15 |
| Year-end P/E | 5.7x |
Revenue increased only about 1.8% CAGR from CY2023 to CY2025, while earnings were highly volatile. Historical PAT moved from a Rs.1.720 million loss in 2021 to Rs.556.927 million in 2022, Rs.69.069 million in 2023, Rs.741.216 million in 2024 and Rs.596.685 million in 2025.
Economic and Market Context
Sri Lankan tea production was broadly flat at 264 million kg in 2025, but national average tea prices declined to Rs.1,167.72/kg from Rs.1,225.17/kg. Rubber production declined from 69 million kg to 66 million kg.
Company performance was pressured by lower crop volumes, adverse weather, labour shortages, the 35% wage increase, higher fertilizer/chemical/fuel costs and geopolitical disruption. Rubber production fell 15%, although its net sale average improved 12% to Rs.878/kg.
Future Potential and Outlook
Management's 2026 strategy centres on:
- Expanding digitalisation from five estates across the estate network, including drones for foliar spraying and crop mapping.
- Conversion of Rye/Wikiliya into a fully organic tea garden.
- Expansion into cinnamon and other diversified crops.
- Pineapple projects, which generated Rs.3.7 million profit in 2025.
- Potential conversion of selected Ratnapura/Kiriella land to oil palm if the government planting restriction is removed.
- Flexible production between crepe rubber and RSS according to market demand.
- Continued factory and field investment; CY2025 capex included Rs.70 million for factories and Rs.49 million for field development.
Product quality remains a competitive strength: the Company recorded 100 tea top prices and 50 rubber top prices during 2025, while Telbedde received major tea-quality awards.
Risks and Challenges
The principal investment risks are weather/climate sensitivity, political and geopolitical risk, labour availability and wage inflation, weak rubber economics, commodity-price volatility, and declining core margins.
The audit opinion for CY2025 was unmodified. Key audit matters nevertheless highlight material estimation sensitivity around Rs.3.886 billion of consumable biological assets, Rs.1.258 billion retirement-benefit obligations and Rs.576 million investment properties. Biological-asset valuations are particularly important because valuation gains materially affect reported earnings.
Shareholder and Corporate Information
Melstacorp PLC owned 72.21% at 2026-06-30. Public holding was 27.79%, represented by 18,611 shareholders; none of the directors or CEO held shares.
The parent holding has decreased from 74.61% reported in Q3 2023, increasing the public float.
Dividend history was Rs.2.00/share for CY2022, nil for CY2023, Rs.1.00 for CY2024 and Rs.0.50 for CY2025. CY2025 payout ratio was only 3.96%.
The latest supplied market snapshot shows a Rs.62.00 close on 2026-08-14, a 90-session range of Rs.59-69 and a 3.33% return over those 90 sessions. Trading liquidity remains modest, with median daily turnover of approximately Rs.223,190. Foreign ownership was approximately 0.91%.
Investment Decision Indicators
Strengths
- Stronger equity and NAV; NAV reached Rs.97.90/share.
- Very low conventional financial debt and substantially lower finance costs.
- High-quality tea positioning and demonstrated premium-price capability.
- Significant biological/land-related asset base.
- Diversification, digitalisation and productivity initiatives provide longer-term optionality.
- Q2 2026 recovered strongly from the Q1 operating shock.
Weaknesses
- H1 2026 core gross margin turned negative.
- Tea margins have compressed sharply and rubber remains gross-loss-making.
- Reported profits depend materially on biological-asset fair-value gains.
- Operating cash flow collapsed to Rs.4.434 million in H1 2026.
- Cash balance is minimal and overdraft usage is increasing.
Opportunities
- Recovery of tea pricing and crop volumes could produce significant operating leverage.
- Wage-cost productivity initiatives, drones and automation could restore margins.
- Cinnamon, organic tea, pineapple and possible oil-palm diversification can reduce dependence on traditional crops.
Threats
- Wage inflation, labour scarcity, adverse weather and disease.
- Commodity-price and currency volatility.
- Geopolitical disruptions affecting export demand and imported inputs.
- Further deterioration in cash conversion despite accounting profitability.
Overall assessment: Balangoda Plantations PLC presently combines strong asset backing, low term debt and valuable tea franchises with rapidly weakening underlying plantation profitability and cash generation. The most important indicators to monitor are tea gross margins, rubber losses, operating cash flow, overdraft usage and the proportion of earnings generated from biological-asset revaluations. A sustained restoration of positive core gross margins and cash flow would materially strengthen the financial case; continued dependence on valuation gains while cash generation weakens would materially increase risk.